Find uplifting stories about heroes, innovations, and solutions
18 results for "pcsk9"
Scientists tested a one-time gene therapy that lowered cholesterol up to 62% in patients, potentially replacing daily pills and injections with a single treatment. The breakthrough could transform how millions manage heart disease risk.
Millions managing stubborn high cholesterol just got a breakthrough option that doesn't require needles. The FDA approved the world's first oral pill that works as powerfully as injections, offering new hope for patients who struggle to lower dangerous cholesterol levels.
Millions with high cholesterol just got a simpler treatment option. The FDA approved Merck's new pill that could replace regular injections for heart disease prevention.
)
A single infusion lowered cholesterol dramatically in a small trial, potentially replacing daily pills with a one-time treatment. If confirmed in larger studies, this could transform heart disease prevention for millions.
A revolutionary gene-editing treatment from Eli Lilly can slash bad cholesterol by up to 62% with just one dose, and the effects last for years. The breakthrough could transform how we prevent heart disease, America's leading killer.
A Dallas researcher who discovered how to dramatically lower bad cholesterol just won one of cardiology's highest honors. Her work has already led to life-saving drugs now used worldwide.
The FDA just approved the first once-daily pill that slashes bad cholesterol by nearly 60%, offering hope to millions of Americans who struggle with high cholesterol. Unlike previous treatments that required injections, this breakthrough comes in a simple pill you can take at home.
The FDA just approved the first cholesterol pill that works like an injection, lowering bad cholesterol by up to 60% without needles. For millions who struggle with high cholesterol, this breakthrough offers a simpler path to protecting their hearts.
A new gene-editing treatment could lower bad cholesterol permanently with just one infusion, eliminating the need for daily medication. Early trial results show a 62% drop in LDL cholesterol that's lasted up to 18 months.
Millions of Americans with high cholesterol now have a new option that doesn't require needles. The FDA just approved Lipfendra, the first daily pill that works like existing injections but costs less and fits easier into daily life.
A groundbreaking once-daily pill just won FDA approval that drops dangerous cholesterol to levels statins can't touch, and it costs a fraction of existing alternatives. For millions at risk of heart disease, this could be the game changer doctors have been waiting for.
A daily pill just approved by the FDA could help millions of Americans finally get their dangerous cholesterol under control. The drug reduced bad cholesterol by up to 60% in clinical trials, giving hope to the 86 million Americans living with high cholesterol.
Millions struggling with dangerously high cholesterol despite taking statins may soon have a powerful new option that comes in pill form. A groundbreaking trial shows the experimental drug enlicitide slashes bad cholesterol by up to 60 percent, matching the effectiveness of costly shots people currently avoid.
Scientists used gene-editing technology to turn off cholesterol genes in a single treatment, dropping levels by up to 62% without daily pills. Two early trials show the permanent fix could transform heart disease prevention.
An experimental pill called enlicitide reduced dangerous cholesterol by up to 60% in patients already taking statins, offering millions a simpler alternative to injections. If approved, the daily pill could become a game-changer for the 650,000 Americans who die from heart disease each year.
A super-fit New Zealand teacher developed life-threatening heart disease despite running 10km daily and eating well, revealing how genetics can silently kill thousands. His story is pushing doctors to demand access to breakthrough drugs that could save lives.
)
A single gene-editing treatment could replace daily cholesterol pills for millions, after early trials showed one infusion cut dangerous LDL levels by 62% for up to 18 months. Scientists used CRISPR technology to modify how the body naturally clears cholesterol from blood.
Scientists studying over one million people discovered a rare genetic mutation that slashes the risk of heart disease and diabetes by 60 percent. The discovery could lead to new treatments that protect everyone from deadly metabolic diseases.